|
Amgen Common
(AMGN)
|
3.4 |
$96M |
-31%
|
417k |
229.92 |
|
Illumina Common
(ILMN)
|
3.3 |
$95M |
-8%
|
258k |
370.00 |
|
Regeneron Pharmaceuticals Common
(REGN)
|
3.0 |
$87M |
-13%
|
179k |
483.11 |
|
Johnson & Johnson Common
(JNJ)
|
3.0 |
$86M |
|
547k |
157.38 |
|
Gilead Sciences Common
(GILD)
|
2.9 |
$82M |
-14%
|
1.4M |
58.26 |
|
Alexion Pharmaceuticals Common
(ALXN)
|
2.8 |
$78M |
+88%
|
502k |
156.24 |
|
Unitedhealth Group Incorporated Common
(UNH)
|
2.7 |
$77M |
+18%
|
219k |
350.68 |
|
Vertex Pharmaceuticals Incorporated Common
(VRTX)
|
2.5 |
$72M |
-23%
|
305k |
236.34 |
|
AbbVie Common
(ABBV)
|
2.3 |
$66M |
-29%
|
620k |
107.15 |
|
Medtronic Shares
(MDT)
|
2.2 |
$63M |
|
535k |
117.14 |
|
Bristol Myers Squibb Company Common
(BMY)
|
2.2 |
$61M |
+4%
|
990k |
62.03 |
|
Biogen Common
(BIIB)
|
2.1 |
$60M |
+15%
|
247k |
244.86 |
|
Thermo Fisher Scientific Common
(TMO)
|
2.1 |
$59M |
+332%
|
128k |
465.78 |
|
Seagen Common
(SGEN)
|
1.8 |
$51M |
NEW
|
294k |
175.14 |
Setup an alert
Hambrecht & Quist Capital Management will file the next quarterly 13-HR in about 3 months. Would you like to be notified?
|
|
Danaher Corporation Common
(DHR)
|
1.7 |
$49M |
+225%
|
220k |
222.14 |
|
Abbott Laboratories Common
(ABT)
|
1.7 |
$47M |
+16%
|
431k |
109.49 |
|
Merck & Co Common
(MRK)
|
1.6 |
$46M |
-46%
|
561k |
81.80 |
|
Eli Lilly and Company Common
(LLY)
|
1.4 |
$40M |
+33%
|
238k |
168.84 |
|
Stryker Corporation Common
(SYK)
|
1.3 |
$38M |
-2%
|
153k |
245.04 |
|
Sarepta Therapeutics Common
(SRPT)
|
1.2 |
$35M |
|
207k |
170.49 |
|
Horizon Therapeutics Shares
(HZNP)
|
1.2 |
$34M |
-22%
|
465k |
73.15 |
|
Humana Common
(HUM)
|
1.2 |
$34M |
-3%
|
83k |
410.27 |
|
Zimmer Biomet Holdings Common
(ZBH)
|
1.2 |
$33M |
+11%
|
214k |
154.09 |
|
Becton, Dickinson and Company Common
(BDX)
|
1.2 |
$33M |
|
132k |
250.22 |
|
HCA Healthcare Common
(HCA)
|
1.0 |
$29M |
+113%
|
175k |
164.46 |
|
Cigna Corporation Common
(CI)
|
1.0 |
$28M |
+90%
|
136k |
208.18 |
|
Neurocrine Biosciences Common
(NBIX)
|
1.0 |
$28M |
+365%
|
294k |
95.85 |
|
ResMed Common
(RMD)
|
1.0 |
$28M |
+36%
|
132k |
212.56 |
|
DexCom Common
(DXCM)
|
1.0 |
$28M |
+302%
|
75k |
369.72 |
|
Waters Corporation Common
(WAT)
|
1.0 |
$27M |
|
110k |
247.42 |
|
Pfizer Common
(PFE)
|
0.9 |
$26M |
-58%
|
705k |
36.81 |
|
Moderna Common
(MRNA)
|
0.9 |
$26M |
-46%
|
248k |
104.47 |
|
Exelixis Common
(EXEL)
|
0.9 |
$25M |
+14%
|
1.3M |
20.07 |
|
BioMarin Pharmaceutical Common
(BMRN)
|
0.9 |
$24M |
-14%
|
278k |
87.69 |
|
Edwards Lifesciences Corporation Common
(EW)
|
0.8 |
$24M |
-8%
|
265k |
91.23 |
|
Steris Shares
(STE)
|
0.8 |
$24M |
|
127k |
189.54 |
|
Alnylam Pharmaceuticals Common
(ALNY)
|
0.8 |
$23M |
|
175k |
129.97 |
|
McKesson Corp. Common
(MCK)
|
0.8 |
$23M |
+21%
|
130k |
173.92 |
|
PRA Health Sciences Common
(PRAH)
|
0.8 |
$22M |
+121%
|
176k |
125.44 |
|
Arena Pharmaceuticals Common
(ARNA)
|
0.7 |
$19M |
+57%
|
253k |
76.83 |
|
Dentsply Sirona Common
(XRAY)
|
0.7 |
$19M |
-10%
|
366k |
52.36 |
|
Mirati Therapeutics Common
(MRTX)
|
0.6 |
$18M |
+6%
|
84k |
219.64 |
|
Allakos Common
(ALLK)
|
0.6 |
$18M |
+103%
|
131k |
140.00 |
|
Argenx SE Sponsored ADR
(ARGX)
|
0.6 |
$18M |
|
62k |
294.10 |
|
ACADIA Pharmaceuticals Common
(ACAD)
|
0.6 |
$18M |
+32%
|
332k |
53.46 |
|
Intuitive Surgical Common
(ISRG)
|
0.6 |
$17M |
-15%
|
21k |
818.09 |
|
IDEXX Laboratories Common
(IDXX)
|
0.6 |
$17M |
|
35k |
499.86 |
|
AstraZeneca Sponsored ADR
(AZN)
|
0.6 |
$17M |
|
344k |
49.99 |
|
Adaptive Biotechnologies Corporation Common
(ADPT)
|
0.6 |
$17M |
+1057%
|
286k |
59.13 |
|
Bio-Techne Corporation Common
(TECH)
|
0.6 |
$16M |
|
52k |
317.56 |
|
Ascendis Pharma A/S Sponsored ADR
(ASND)
|
0.6 |
$16M |
-23%
|
96k |
166.78 |
|
Sutro Biopharma Common
(STRO)
|
0.5 |
$15M |
+9%
|
703k |
21.71 |
|
NovoCure Ordinary Shares
(NVCR)
|
0.5 |
$15M |
-24%
|
88k |
173.04 |
|
Guardant Health Common
(GH)
|
0.5 |
$15M |
|
118k |
128.88 |
|
Fate Therapeutics Common
(FATE)
|
0.5 |
$15M |
-23%
|
166k |
90.93 |
|
CVS Health Corporation Common
(CVS)
|
0.5 |
$15M |
-43%
|
220k |
68.30 |
|
Turning Point Therapeutics Common
(TPTX)
|
0.5 |
$15M |
+2001%
|
119k |
121.85 |
|
Blueprint Medicines Corporation Common
(BPMC)
|
0.5 |
$14M |
-27%
|
123k |
112.15 |
|
Novartis Sponsored ADR
(NVS)
|
0.5 |
$14M |
-4%
|
145k |
94.43 |
|
IQVIA Holdings Common
(IQV)
|
0.5 |
$14M |
-7%
|
76k |
179.17 |
|
Ultragenyx Pharmaceutical Common
(RARE)
|
0.5 |
$14M |
|
98k |
138.43 |
|
Syneos Health Class A
(SYNH)
|
0.5 |
$13M |
+80%
|
195k |
68.13 |
|
Sage Therapeutics Common
(SAGE)
|
0.5 |
$13M |
+58%
|
152k |
86.51 |
|
Laboratory Corporation of America Holdings Sponsored ADR
(LH)
|
0.5 |
$13M |
-7%
|
65k |
203.55 |
|
Welltower Common
(WELL)
|
0.5 |
$13M |
|
203k |
64.62 |
|
Quest Diagnostics Incorporated Common
(DGX)
|
0.5 |
$13M |
|
110k |
119.17 |
|
Iovance Biotherapeutics Common
(IOVA)
|
0.4 |
$13M |
|
271k |
46.40 |
|
Apellis Pharmaceuticals Common
(APLS)
|
0.4 |
$12M |
|
216k |
57.20 |
|
Trillium Therapeutics Common
(TRIL)
|
0.4 |
$12M |
+82%
|
818k |
14.71 |
|
Anthem Common
(ANTM)
|
0.4 |
$12M |
|
37k |
321.09 |
|
CRISPR Therapeutics Namen AKT
(CRSP)
|
0.4 |
$12M |
|
76k |
153.11 |
|
Intra-Cellular Therapies Common
(ITCI)
|
0.4 |
$12M |
+288%
|
366k |
31.80 |
|
Teladoc Health Common
(TDOC)
|
0.4 |
$11M |
NEW
|
57k |
199.96 |
|
Mettler-Toledo International Common
(MTD)
|
0.4 |
$11M |
|
9.8k |
1139.69 |
|
Jazz Pharmaceuticals Shares
(JAZZ)
|
0.4 |
$11M |
|
68k |
165.06 |
|
Omega Healthcare Investors Common
(OHI)
|
0.4 |
$11M |
|
306k |
36.32 |
|
Ionis Pharmaceuticals Common
(IONS)
|
0.4 |
$11M |
|
193k |
56.54 |
|
Galera Therapeutics Common
(GRTX)
|
0.4 |
$11M |
|
1.0M |
10.23 |
|
Genmab A/S Sponsored ADS
(GMAB)
|
0.4 |
$11M |
+39%
|
259k |
40.66 |
|
Ventas Common
(VTR)
|
0.4 |
$10M |
|
208k |
49.04 |
|
Arrowhead Pharmaceuticals Common
(ARWR)
|
0.4 |
$10M |
+79%
|
133k |
76.73 |
|
United Therapeutics Corporation Class B
(UTHR)
|
0.3 |
$9.6M |
|
64k |
151.80 |
|
Amicus Therapeutics Common
(FOLD)
|
0.3 |
$9.4M |
|
406k |
23.09 |
|
Zoetis Class A
(ZTS)
|
0.3 |
$9.4M |
|
57k |
165.50 |
|
Medical Properties Trust Common
(MPW)
|
0.3 |
$9.0M |
|
412k |
21.79 |
|
ChemoCentryx Common
(CCXI)
|
0.3 |
$8.9M |
|
144k |
61.92 |
|
Kura Oncology Common
(KURA)
|
0.3 |
$8.9M |
+360%
|
274k |
32.66 |
|
Sabra Health Care REIT Common
(SBRA)
|
0.3 |
$8.9M |
|
511k |
17.37 |
|
Boston Scientific Corporation Common
(BSX)
|
0.3 |
$8.8M |
-66%
|
246k |
35.95 |
|
Physicians Realty Trust Common
(DOC)
|
0.3 |
$8.8M |
|
496k |
17.80 |
|
Karuna Therapeutics Common
(KRTX)
|
0.3 |
$8.7M |
+103%
|
85k |
101.59 |
|
Novavax Common
(NVAX)
|
0.3 |
$8.5M |
+564%
|
77k |
111.51 |
|
Molina Healthcare Common
(MOH)
|
0.3 |
$8.5M |
-6%
|
40k |
212.68 |
|
Exact Sciences Corporation Common
(EXAS)
|
0.3 |
$8.4M |
+319%
|
64k |
132.48 |
|
Incyte Corporation Common
(INCY)
|
0.3 |
$8.1M |
-38%
|
93k |
86.97 |
|
Theravance Biopharma Common
(TBPH)
|
0.3 |
$8.1M |
+52%
|
456k |
17.77 |
|
BeiGene Sponsored ADR
(BGNE)
|
0.3 |
$7.3M |
|
28k |
258.38 |
|
FibroGen Common
(FGEN)
|
0.3 |
$7.2M |
|
194k |
37.09 |
|
Owens & Minor Common
(OMI)
|
0.3 |
$7.2M |
NEW
|
266k |
27.05 |
|
LTC Properties Common
(LTC)
|
0.2 |
$7.1M |
|
182k |
38.91 |
|
Teva Pharmaceutical Industries Sponsored ADR
(TEVA)
|
0.2 |
$7.0M |
-7%
|
730k |
9.65 |
|
Charles River Laboratories International Common
(CRL)
|
0.2 |
$7.0M |
-8%
|
28k |
249.88 |
|
TG Therapeutics Common
(TGTX)
|
0.2 |
$6.9M |
NEW
|
133k |
52.02 |
|
Xencor Common
(XNCR)
|
0.2 |
$6.5M |
|
148k |
43.63 |
|
Arvinas Common
(ARVN)
|
0.2 |
$6.2M |
NEW
|
74k |
84.93 |
|
Agilent Technologies Common
(A)
|
0.2 |
$6.2M |
|
53k |
118.50 |
|
Teleflex Incorporated Common
(TFX)
|
0.2 |
$6.2M |
-12%
|
15k |
411.57 |
|
Denali Therapeutics Common
(DNLI)
|
0.2 |
$6.1M |
NEW
|
72k |
83.77 |
|
Revance Therapeutics Common
(RVNC)
|
0.2 |
$6.1M |
+149%
|
214k |
28.34 |
|
Cogent Biosciences Common
|
0.2 |
$6.0M |
NEW
|
538k |
11.23 |
|
Atreca Class A Common
(BCEL)
|
0.2 |
$5.7M |
|
352k |
16.15 |
|
Amedisys Common
(AMED)
|
0.2 |
$5.7M |
|
19k |
293.32 |
|
Scholar Rock Holding Corporation Common
(SRRK)
|
0.2 |
$5.6M |
NEW
|
116k |
48.53 |
|
Align Technology Common
(ALGN)
|
0.2 |
$5.4M |
|
10k |
534.41 |
|
PerkinElmer Common
(PKI)
|
0.2 |
$5.3M |
-3%
|
37k |
143.50 |
|
Verona Pharma Sponsored ADR
(VRNA)
|
0.2 |
$5.3M |
+58%
|
752k |
7.00 |
|
Forma Therapeutics Holdings Shares
(FMTX)
|
0.2 |
$5.2M |
NEW
|
150k |
34.90 |
|
Zai Lab Adr
(ZLAB)
|
0.2 |
$5.1M |
|
38k |
135.33 |
|
Centene Corporation Common
(CNC)
|
0.2 |
$5.1M |
-81%
|
84k |
60.03 |
|
Reata Pharmaceuticals Class A
(RETA)
|
0.2 |
$4.7M |
-50%
|
38k |
123.63 |
|
Healthpeak Properties Common
(PEAK)
|
0.2 |
$4.5M |
|
150k |
30.23 |
|
Novo Nordisk A/S Sponsored ADR
(NVO)
|
0.2 |
$4.5M |
-51%
|
65k |
69.85 |
|
uniQure Shares
(QURE)
|
0.2 |
$4.5M |
+98%
|
125k |
36.13 |
|
Addus HomeCare Corporation Common
(ADUS)
|
0.2 |
$4.4M |
+135%
|
38k |
117.08 |
|
Smith & Nephew Shares
(SNN)
|
0.1 |
$4.2M |
|
100k |
42.17 |
|
Aurinia Pharmaceuticals Common
(AUPH)
|
0.1 |
$4.2M |
|
301k |
13.83 |
|
Amarin Corporation Sponsored ADR
(AMRN)
|
0.1 |
$4.2M |
|
850k |
4.89 |
|
Praxis Precision Medicines Common
|
0.1 |
$4.1M |
NEW
|
75k |
55.03 |
|
Axonics Modulation Technologies Common
(AXNX)
|
0.1 |
$4.0M |
+316%
|
81k |
49.93 |
|
Sanofi Sponsored ADR
(SNY)
|
0.1 |
$4.0M |
-78%
|
82k |
48.59 |
|
Ardelyx Common
(ARDX)
|
0.1 |
$3.9M |
|
608k |
6.47 |
|
Takeda Pharmaceutical Company Sponsored ADS
(TAK)
|
0.1 |
$3.8M |
|
210k |
18.20 |
|
Endo International Shares
(ENDP)
|
0.1 |
$3.8M |
|
532k |
7.18 |
|
Y-mAbs Therapeutics Common
(YMAB)
|
0.1 |
$3.8M |
|
77k |
49.51 |
|
Pieris Pharmaceuticals Common
(PIRS)
|
0.1 |
$3.6M |
|
1.4M |
2.50 |
|
Abiomed Common
(ABMD)
|
0.1 |
$3.5M |
-11%
|
11k |
324.18 |
|
Deciphera Pharmaceuticals Common
(DCPH)
|
0.1 |
$3.5M |
|
61k |
57.06 |
|
Alkermes Shares
(ALKS)
|
0.1 |
$3.4M |
|
170k |
19.95 |
|
Tenet Healthcare Corporation Common
(THC)
|
0.1 |
$3.3M |
-14%
|
83k |
39.93 |
|
Insmed Incorporated Common
(INSM)
|
0.1 |
$3.3M |
|
98k |
33.29 |
|
Koninklijke Philips NY Reg Sh
(PHG)
|
0.1 |
$3.1M |
|
57k |
54.17 |
|
Healthcare Realty Trust Incorporated Common
(HR)
|
0.1 |
$3.1M |
|
104k |
29.60 |
|
Nektar Therapeutics Common
(NKTR)
|
0.1 |
$3.1M |
-31%
|
180k |
17.00 |
|
Kadmon Holdings Common
(KDMN)
|
0.1 |
$3.0M |
|
714k |
4.15 |
|
Heron Therapeutics Common
(HRTX)
|
0.1 |
$2.8M |
|
131k |
21.16 |
|
Helix Acquisition Corp. Class A Common
|
0.1 |
$2.7M |
NEW
|
250k |
10.83 |
|
Zymeworks Common
(ZYME)
|
0.1 |
$2.6M |
|
56k |
47.27 |
|
Eidos Therapeutics Common
(EIDX)
|
0.1 |
$2.6M |
|
20k |
131.60 |
|
Medpace Holdings Common
(MEDP)
|
0.1 |
$2.6M |
|
19k |
139.21 |
|
Axsome Therapeutics Common
(AXSM)
|
0.1 |
$2.6M |
|
32k |
81.48 |
|
Hologic Common
(HOLX)
|
0.1 |
$2.4M |
|
33k |
72.84 |
|
MorphoSys Sponsored ADS
(MOR)
|
0.1 |
$2.3M |
|
82k |
28.34 |
|
Inogen Common
(INGN)
|
0.1 |
$2.3M |
|
51k |
44.68 |
|
Perrigo Company Shares
(PRGO)
|
0.1 |
$2.3M |
|
51k |
44.73 |
|
Global Medical REIT Common
(GMRE)
|
0.1 |
$2.3M |
|
175k |
13.06 |
|
Bausch Health Companies Common
(BHC)
|
0.1 |
$2.1M |
-14%
|
101k |
20.80 |
|
NuCana Sponsored ADR
(NCNA)
|
0.1 |
$2.1M |
|
461k |
4.49 |
|
Alcon Ordinary Shares
(ALC)
|
0.1 |
$2.1M |
-14%
|
31k |
65.97 |
|
Molecular Templates Common
(MTEM)
|
0.1 |
$2.1M |
|
220k |
9.39 |
|
Healthcare Trust of America Common
(HTA)
|
0.1 |
$1.9M |
|
71k |
27.54 |
|
Intercept Pharmaceuticals Common
(ICPT)
|
0.1 |
$1.9M |
|
77k |
24.71 |
|
Zogenix Common
(ZGNX)
|
0.1 |
$1.8M |
-73%
|
89k |
19.99 |
|
Harpoon Therapeutics Common
(HARP)
|
0.1 |
$1.8M |
|
106k |
16.61 |
|
Milestone Pharmaceuticals Common
(MIST)
|
0.1 |
$1.7M |
+18%
|
254k |
6.70 |
|
Gritstone Oncology Common
(GRTS)
|
0.1 |
$1.7M |
NEW
|
419k |
3.94 |
|
Avadel Pharmaceuticals Sponsored ADR
(AVDL)
|
0.1 |
$1.6M |
|
234k |
6.68 |
|
Affimed Common
(AFMD)
|
0.1 |
$1.6M |
NEW
|
268k |
5.82 |
|
Magenta Therapeutics Common
(MGTA)
|
0.1 |
$1.5M |
|
192k |
7.84 |
|
Dicerna Pharmaceuticals Common
(DRNA)
|
0.1 |
$1.5M |
|
68k |
22.02 |
|
Madrigal Pharmaceuticals Common
(MDGL)
|
0.1 |
$1.5M |
|
13k |
111.17 |
|
Diversified Healthcare Trust Common
(DHC)
|
0.1 |
$1.5M |
|
358k |
4.12 |
|
New Senior Investment Group Common
(SNR)
|
0.0 |
$1.3M |
|
256k |
5.18 |
|
Allogene Therapeutics Common
(ALLO)
|
0.0 |
$1.2M |
NEW
|
48k |
25.24 |
|
Health Care Select Sector SPDR Fund SBI Healthcare
(XLV)
|
0.0 |
$1.1M |
|
10k |
113.48 |
|
ImmunoGen Common
(IMGN)
|
0.0 |
$1.1M |
|
168k |
6.45 |
|
Esperion Therapeutics Common
(ESPR)
|
0.0 |
$1.1M |
|
42k |
26.00 |
|
Karyopharm Therapeutics Common
(KPTI)
|
0.0 |
$1.0M |
|
66k |
15.48 |
|
Bristol Myers Squibb Company Right
(BMY.R)
|
0.0 |
$1.0M |
|
1.5M |
0.69 |
|
Regenxbio Common
(RGNX)
|
0.0 |
$984k |
|
22k |
45.35 |
|
Aerie Pharmaceuticals Common
(AERI)
|
0.0 |
$901k |
|
67k |
13.51 |
|
AC Immune SA Shares
(ACIU)
|
0.0 |
$888k |
|
172k |
5.17 |
|
Community Health Systems Common
(CYH)
|
0.0 |
$875k |
|
118k |
7.43 |
|
Grifols Sponsored ADR
(GRFS)
|
0.0 |
$874k |
|
47k |
18.45 |
|
Ovid Therapeutics Sponsored ADR
(OVID)
|
0.0 |
$861k |
|
373k |
2.31 |
|
VYNE Therapeutics Common
(VYNE)
|
0.0 |
$856k |
|
542k |
1.58 |
|
Universal Health Realty Income Trust Shares
(UHT)
|
0.0 |
$724k |
|
11k |
64.31 |
|
Community Healthcare Trust Incorporated Common
(CHCT)
|
0.0 |
$702k |
|
15k |
47.11 |
|
National Health Investors Common
(NHI)
|
0.0 |
$694k |
|
10k |
69.14 |
|
Assertio Holdings Common
(ASRT)
|
0.0 |
$587k |
|
1.6M |
0.36 |
|
Corbus Pharmaceuticals Holdings Common
(CRBP)
|
0.0 |
$517k |
|
414k |
1.25 |
|
CymaBay Therapeutics Common
(CBAY)
|
0.0 |
$506k |
|
88k |
5.74 |
|
Clearside Biomedical Common
(CLSD)
|
0.0 |
$453k |
|
165k |
2.74 |
|
Spectrum Pharmaceuticals Common
(SPPI)
|
0.0 |
$391k |
|
115k |
3.41 |
|
Cellectis Sponsored ADR
(CLLS)
|
0.0 |
$324k |
-89%
|
12k |
27.10 |
|
Viatris Common
(VTRS)
|
0.0 |
$251k |
NEW
|
13k |
18.73 |
|
Five Star Senior Living Common
(FVE)
|
0.0 |
$167k |
|
24k |
6.89 |
|
ARCA biopharma Common
(ABIO)
|
0.0 |
$130k |
|
33k |
4.00 |
|
Celldex Therapeutics Common
(CLDX)
|
0.0 |
$124k |
|
7.1k |
17.58 |
|
Bellicum Pharmaceuticals Common
(BLCM)
|
0.0 |
$21k |
|
6.0k |
3.50 |
|
Tetraphase Pharmaceuticals Common
|
0.0 |
$9.0k |
|
43k |
0.21 |